GLRX3

Glutaredoxin 3
PDB rendering based on 1wik.
Available structures PDB Ortholog search: PDBe, RCSB List of PDB id codes 2DIY​, 2WZ9​, 2YAN​, 3ZYW​
Identifiers
Symbols	GLRX3 ; GLRX4; GRX3; GRX4; PICOT; TXNL2; TXNL3
External IDs	OMIM: 612754 MGI: 1353653 HomoloGene: 4769 GeneCards: GLRX3 Gene
Gene ontology Molecular function • protein kinase C binding • protein binding • electron carrier activity • protein disulfide oxidoreductase activity • poly(A) RNA binding • metal ion binding • iron-sulfur cluster binding Cellular component • nucleus • cell cortex • Z disc • dendrite • extracellular exosome Biological process • regulation of the force of heart contraction • negative regulation of cardiac muscle hypertrophy • cell redox homeostasis • oxidation-reduction process Sources: Amigo / QuickGO
RNA expression pattern
More reference expression data
Orthologs
Species	Human	Mouse
Entrez	10539	30926
Ensembl	ENSG00000108010	ENSMUSG00000031068
UniProt	O76003	Q9CQM9
RefSeq (mRNA)	NM_001199868	NM_023140
RefSeq (protein)	NP_001186797	NP_075629
Location (UCSC)	Chr 10: 130.14 – 130.18 Mb	Chr 7: 137.44 – 137.47 Mb
PubMed search

Glutaredoxin-3 is a protein that in humans is encoded by the GLRX3 gene.^[1][2][3]

Interactions

GLRX3 has been shown to interact with PRKCQ.^[1]

References

1. Witte S, Villalba M, Bi K, Liu Y, Isakov N, Altman A (Feb 2000). "Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kappaB pathways by PICOT, a novel protein kinase C-interacting protein with a thioredoxin homology domain". J Biol Chem 275 (3): 1902–9. doi:10.1074/jbc.275.3.1902. PMID 10636891.
2. Stanchi F, Bertocco E, Toppo S, Dioguardi R, Simionati B, Cannata N, Zimbello R, Lanfranchi G, Valle G (Jan 2001). "Characterization of 16 novel human genes showing high similarity to yeast sequences". Yeast 18 (1): 69–80. doi:10.1002/1097-0061(200101)18:1<69::AID-YEA647>3.0.CO;2-H. PMID 11124703.
3. "Entrez Gene: TXNL2 thioredoxin-like 2".

Further reading

• Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
• Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
• Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
• Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
• Rual JF, Venkatesan K, Hao T; et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
• Ewing RM, Chu P, Elisma F; et al. (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Mol. Syst. Biol. 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.